West Pharmaceutical Services | WST - Debt



West Pharmaceutical Services reported $202.6M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Align Technology USD 118.54M 118.54M Mar/2025
Avanos Medical USD 137.3M 29.9M Jun/2025
Baxter International USD 10.31B 2.82B Mar/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Charles River Laboratories USD 2.79B 275.28M Jun/2025
Cooper Companies USD 2.48B 107.1M Jul/2025
Dentsply International USD 2.49B 159M Jun/2025
Haemonetics USD 1.22B 6K Jun/2025
ICU Medical USD 1.39B 148.5M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Medtronic USD 28.52B 1.91B Apr/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Neogen USD 894.11M 1M May/2025
Quidel USD 2.79B 293M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Solventum Corp 7.91B 97M Mar/2025
STAAR Surgical USD 40.52M 40.52M Jun/2025
Terumo JPY 174.84B 14.98B Mar/2025
West Pharmaceutical Services USD 202.6M 0 Jun/2025